Inherited cancer syndromes in 220 Italian ovarian cancer patients

被引:6
作者
Carnevali, I [1 ,2 ]
Riva, C. [2 ,3 ]
Chiaravalli, A. M. [1 ,2 ]
Sahnane, N. [2 ,3 ]
Di Lauro, E. [1 ]
Viel, A. [4 ]
Rovera, F. [2 ,5 ]
Formenti, G. [6 ]
Ghezzi, F. [2 ,6 ]
Sessa, F. [2 ,3 ]
Tibiletti, M. G. [1 ,2 ]
机构
[1] ASST Sette Laghi, Osped Circolo, Dept Pathol, Via O Rossi 9, I-21100 Varese, Italy
[2] Univ Insubria, Res Ctr Study Hereditary & Familial Tumors, Dept Med & Surg, Varese, Italy
[3] Univ Insubria, Dept Med & Surg, Varese, Italy
[4] Ctr Riferimento Oncol Aviano CRO IRCCS, Unit Funct Oncogenom & Genet, Aviano, PN, Italy
[5] ASST Settelaghi, Breast Unit, Osped Circolo, Varese, Italy
[6] ASST Settelaghi, Osped F Del Ponte, Dept Obstet & Gynaecol, Varese, Italy
关键词
Ovarian cancer; HBOC; Lynch syndrome; MMR; Genetic counselling; RISK-REDUCING SURGERY; HEREDITARY BREAST; LYNCH; MUTATIONS; RECOMMENDATIONS; PREDISPOSITION; CLASSIFICATION; BRCA1; WOMEN;
D O I
10.1016/j.cancergen.2019.06.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: A subsets of ovarian carcinomas (OCs) are related to inherited conditions including Hereditary Breast and Ovarian Cancers (HBOC) and Lynch Syndrome (LS). The identification of inherited conditions using genetic testing might be a strategic model for cancer prevention that include benefits for the ovarian cancer patients and for their family members. Methods: We describe a retrospective Italian experience for the identification of inherited conditions in 232 patients affected by OCs using both somatic and germline analyses. Results: Immunohistochemical and microsatellite analyses performed on OCs identified 20 out of 101 MMR defective cancers and 15 of these were from patients carriers of the MMR germline pathogenetic variants. BRCA1 and BRCA2 testing offered to 198 OC patients revealed 67 (34%) pathogenetic variant carriers of BRCA1/2 genes. Interestingly LS patients revealed a mean age of OC onset of 45.4 years, which was significantly lower than the mean age of OCs onset of HBOC patients. Conclusions: Somatic and germline analyses offered to OC patients has proved to be an efficient strategy for the identification of inherited conditions involving OC also in absence of suggestive family histories. The identification of LS and HBOC syndromes through OC patients is an effective tool for OC prevention.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 28 条
[1]   BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group [J].
Alsop, Kathryn ;
Fereday, Sian ;
Meldrum, Cliff ;
deFazio, Anna ;
Emmanuel, Catherine ;
George, Joshy ;
Dobrovic, Alexander ;
Birrer, Michael J. ;
Webb, Penelope M. ;
Stewart, Colin ;
Friedlander, Michael ;
Fox, Stephen ;
Bowtell, David ;
Mitchell, Gillian .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2654-2663
[2]   Somatic Testing on Gynecological Cancers Improve the Identification of Lynch Syndrome [J].
Carnevali, Ileana ;
Libera, Laura ;
Chiaravalli, Annamaria ;
Sahnane, Nora ;
Furlan, Daniela ;
Viel, Alessandra ;
Cini, Giulia ;
Cimetti, Laura ;
Rossi, Thomas ;
Formenti, Giorgio ;
Ghezzi, Fabio ;
Riva, Cristina ;
Sessa, Fausto ;
Tibiletti, Maria Grazia .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (07) :1543-1549
[3]   The role of histological investigation in prognostic evaluation of advanced gastric cancer - Analysis of histological structure and molecular changes compared with invasive pattern and stage [J].
Chiaravalli, AM ;
Cornaggia, M ;
Furlan, D ;
Capella, C ;
Fiocca, R ;
Tagliabue, G ;
Klersy, C ;
Solcia, E .
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 2001, 439 (02) :158-169
[4]   Concomitant mutation and epimutation of the MLH1 gene in a Lynch syndrome family [J].
Cini, Giulia ;
Carnevali, Ileana ;
Quaia, Michele ;
Chiaravalli, Anna Maria ;
Sala, Paola ;
Giacomini, Elisa ;
Maestro, Roberta ;
Tibiletti, Maria Grazia ;
Viel, Alessandra .
CARCINOGENESIS, 2015, 36 (04) :452-458
[5]   NCCN Guidelines® Insights Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017 Featured Updates to the NCCN Guidelines [J].
Daly, Mary B. ;
Pilarski, Robert ;
Berry, Michael ;
Buys, Saundra S. ;
Farmer, Meagan ;
Friedman, Susan ;
Garber, Judy E. ;
Kauff, Noah D. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison ;
Litton, Jennifer K. ;
Madlensky, Lisa ;
Merajver, Sofia D. ;
Offit, Kenneth ;
Pal, Tuya ;
Reiser, Gwen ;
Shannon, Kristen Mahoney ;
Swisher, Elizabeth ;
Vinayak, Shaveta ;
Voian, Nicoleta C. ;
Weitzel, Jeffrey N. ;
Wick, Myra J. ;
Wiesner, Georgia L. ;
Dwyer, Mary ;
Darlow, Susan .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01) :9-19
[6]   Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015 Featured Updates to the NCCN Guidelines [J].
Daly, Mary B. ;
Pilarski, Robert ;
Axilbund, Jennifer E. ;
Berry, Michael ;
Buys, Saundra S. ;
Crawford, Beth ;
Farmer, Meagan ;
Friedman, Susan ;
Garber, Judy E. ;
Khan, Seema ;
Klein, Catherine ;
Kohlmann, Wendy ;
Kurian, Allison ;
Litton, Jennifer K. ;
Madlensky, Lisa ;
Marcom, P. Kelly ;
Merajver, Sofia D. ;
Offit, Kenneth ;
Pal, Tuya ;
Rana, Huma ;
Reiser, Gwen ;
Robson, Mark E. ;
Shannon, Kristen Mahoney ;
Swisher, Elizabeth ;
Voian, Nicoleta C. ;
Weitzel, Jeffrey N. ;
Whelan, Alison ;
Wick, Myra J. ;
Wiesner, Georgia L. ;
Dwyer, Mary ;
Kumar, Rashmi ;
Darlow, Susan .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2016, 14 (02) :153-162
[7]   Genetic predisposition in gynecologic cancers [J].
Daniels, Molly S. ;
Lu, Karen H. .
SEMINARS IN ONCOLOGY, 2016, 43 (05) :543-547
[8]   Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond [J].
Hall, M. J. ;
Obeid, E. I. ;
Schwartz, S. C. ;
Mantia-Smaldone, G. ;
Forman, A. D. ;
Daly, M. B. .
GYNECOLOGIC ONCOLOGY, 2016, 140 (03) :565-574
[9]   Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer [J].
MacInnis, Robert J. ;
Pike, Malcolm C. ;
Hopper, John L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (24) :2403-2404
[10]   The Role of Risk-Reducing Surgery in Hereditary Breast and Ovarian Cancer [J].
Hartmann, Lynn C. ;
Lindor, Noralane M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (05) :454-468